March 2, 2020
Smith Drug Company Inventory Statement
Smith Drug Company is committed to ensuring the safety and security of our supply chain. There are concerns being raised in the media about potential supply issues related to events surrounding COVID-19, and we want you to know that we are carefully monitoring the situation.
At this time, we are in daily contact with our vendor partners and regularly monitoring our inventory levels. We are at or above our normal levels and continue to order inventory to ensure we remain in a strong position. It is worth noting that none of our suppliers have notified us of any impending service interruptions.
We recommend our customers maintain adequate supplies to meet their needs and communicate with us if they wish to change normal ordering patterns. We will continue to update our customers as the situation changes or additional information is available.